UONDDL
PRNB

University of Notre Dame du Lac’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

University of Notre Dame du Lac’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,982
Closed -$1.01M – 63
2020
Q1 		$1.01M Buy
+16,982
New +$990K 0.31% 41
2019
Q4 		– Sell
-24,572
Closed -$694K – 64
2019
Q3 		$694K Buy
+24,572
New +$901K 0.21% 54

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

University of Notre Dame du Lac's PRNB Position: Q2 2020 in Review

University of Notre Dame du Lac sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q2 2020, closing a stake of 16,982 shares — an estimated $1.01M sold.

University of Notre Dame du Lac first reported a position in PRNB in Q3 2019 and held it in 2 quarters. The position peaked at $1.01M in Q1 2020. 137 funds tracked by Wall St. Rank hold PRNB as of Q2 2020.

  • University of Notre Dame du Lac reported no remaining Principia Biopharma Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • University of Notre Dame du Lac sold 16,982 Principia Biopharma Inc. Common Stock shares in Q2 2020, an estimated $1.01M.
  • University of Notre Dame du Lac first reported a position in Principia Biopharma Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • University of Notre Dame du Lac's Principia Biopharma Inc. Common Stock position peaked at $1.01M in Q1 2020.
  • 137 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q2 2020.

Based on University of Notre Dame du Lac's 13F filing for Q2 2020, filed 14 Aug 2020.